(Press-News.org) LA JOLLA, CA – March 3, 2011 – Unexpected results from a Scripps Research Institute and ModGene, LLC study could completely alter scientists' ideas about Alzheimer's disease—pointing to the liver instead of the brain as the source of the "amyloid" that deposits as brain plaques associated with this devastating condition. The findings could offer a relatively simple approach for Alzheimer's prevention and treatment.
The study was published online today in The Journal of Neuroscience Research.
In the study, the scientists used a mouse model for Alzheimer's disease to identify genes that influence the amount of amyloid that accumulates in the brain. They found three genes that protected mice from brain amyloid accumulation and deposition. For each gene, lower expression in the liver protected the mouse brain. One of the genes encodes presenilin—a cell membrane protein believed to contribute to the development of human Alzheimer's.
"This unexpected finding holds promise for the development of new therapies to fight Alzheimer's," said Scripps Research Professor Greg Sutcliffe, who led the study. "This could greatly simplify the challenge of developing therapies and prevention."
An estimated 5.1 million Americans have Alzheimer's disease, including nearly half of people age 85 and older. By 2050, the number of people age 65 and over with this disease will range from 11 million to 16 million unless science finds a way to prevent or effectively treat it. In addition to the human misery caused by the disease, there is the unfathomable cost. A new report from the Alzheimer's Association shows that in the absence of disease-modifying treatments, the cumulative costs of care for people with Alzheimer's from 2010 to 2050 will exceed $20 trillion.
A Genetic Search-and-Find Mission
In trying to help solve the Alzheimer's puzzle, in the past few years Sutcliffe and his collaborators have focused their research on naturally occurring, inherited differences in neurological disease susceptibility among different mouse strains, creating extensive databases cataloging gene activity in different tissues, as measured by mRNA accumulation. These data offer up maps of trait expression that can be superimposed on maps of disease modifier genes.
As is the case with nearly all scientific discovery, Sutcliffe's research builds on previous findings. Several years ago, researchers at Case Western Reserve mapped three genes that modify the accumulation of pathological beta amyloid in the brains of a transgenic mouse model of Alzheimer's disease to large chromosomal regions, each containing hundreds of genes. The Case Western scientists used crosses between the B6 and D2 strains of mice, studying more than 500 progeny.
Using the results from this study, Sutcliffe turned his databases of gene expression to the mouse model of Alzheimer's, looking for differences in gene expression that correlated with differences in disease susceptibility between the B6 and D2 strains. This intensive work involved writing computer programs that identified each genetic difference that distinguished the B6 and D2 genomes, then running mathematical correlation analysis (known as regression analysis) of each difference. Correlations were made between the genotype differences (B6 or D2) and the amount of mRNA product made from each of the more than 25,000 genes in a particular tissue in the 40 recombinant inbred mouse strains. These correlations were repeated 10 times to cover 10 tissues, the liver being one of them.
"A key aspect of this work was learning how to ask questions of massive data sets to glean information about the identities of heritable modifier genes," Sutcliffe said. "This was novel and, in a sense, groundbreaking work: we were inventing a new way to identify modifier genes, putting all of these steps together and automating the process. We realized we could learn about how a transgene's pathogenic effect was being modified without studying the transgenic mice ourselves."
Looking for a Few Good Candidates
Sutcliffe's gene hunt offered up good matches, candidates, for each of the three disease modifier genes discovered by the Case Western scientists, and one of these candidates—the mouse gene corresponding to a gene known to predispose humans carrying particular variations of it to develop early-onset Alzheimer's disease—was of special interest to his team.
"The product of that gene, called Presenilin2, is part of an enzyme complex involved in the generation of pathogenic beta amyloid," Sutcliffe explained. "Unexpectedly, heritable expression of Presenilin2 was found in the liver but not in the brain. Higher expression of Presenilin2 in the liver correlated with greater accumulation of beta amyloid in the brain and development of Alzheimer's-like pathology."
This finding suggested that significant concentrations of beta amyloid might originate in the liver, circulate in the blood, and enter the brain. If true, blocking production of beta amyloid in the liver should protect the brain.
To test this hypothesis, Sutcliffe's team set up an in vivo experiment using wild-type mice since they would most closely replicate the natural beta amyloid-producing environment. "We reasoned that if brain amyloid was being born in the liver and transported to the brain by the blood, then that should be the case in all mice," Sutcliffe said, "and one would predict in humans, too."
The mice were administered imatinib (trade name Gleevec, an FDA-approved cancer drug), a relatively new drug currently approved for treatment of chronic myelogenous leukemia and gastrointestinal tumors. The drug potently reduces the production of beta amyloid in neuroblastoma cells transfected by amyloid precursor protein (APP) and also in cell-free extracts prepared from the transfected cells. Importantly, Gleevec has poor penetration of the blood-brain barrier in both mice and humans.
"This characteristic of the drug is precisely why we chose to use it," Sutcliffe explained. "Because it doesn't penetrate the blood-brain barrier, we were able to focus on the production of amyloid outside of the brain and how that production might contribute to amyloid that accumulates in the brain, where it is associated with disease."
The mice were injected with Gleevec twice a day for seven days; then plasma and brain tissue were collected, and the amount of beta amyloid in the blood and brain was measured. The findings: the drug dramatically reduced beta amyloid not only in the blood, but also in the brain where the drug cannot penetrate. Thus, an appreciable portion of brain amyloid must originate outside of the brain, and imatinib represents a candidate for preventing and treating Alzheimer's.
As for the future of this research, Sutcliffe says he hopes to find a partner and investors to move the work into clinical trials and new drug development.
###
In addition to Sutcliffe, the authors of the study, titled "Peripheral reduction of β-amyloid is sufficient to reduce brain Aβ: implications for Alzheimer's disease," include Peter Hedlund and Elizabeth Thomas of Scripps Research, and Floyd Bloom and Brian Hilbush of ModGene, LLC, which funded the project. For more information, see http://onlinelibrary.wiley.com/doi/10.1002/jnr.22603/abstract .
About The Scripps Research Institute
The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neuroscience, and vaccine development, as well as for its insights into autoimmune, cardiovascular, and infectious disease. Headquartered in La Jolla, California, the institute also includes a campus in Jupiter, Florida, where scientists focus on drug discovery and technology development in addition to basic biomedical science. Scripps Research currently employs about 3,000 scientists, staff, postdoctoral fellows, and graduate students on its two campuses. The institute's graduate program, which awards Ph.D. degrees in biology and chemistry, is ranked among the top ten such programs in the nation. For more information, see www.scripps.edu .
About ModGene
ModGene is a preclinical research company specializing in mouse modifier genetics. Its core technology makes correlations between naturally occurring, heritable differences in disease susceptibility among different strains of mice and naturally occurring, heritable differences in the activities of the genes of these mice. This allows the company to gain insights into which proteins represent targets for the development of drugs that modify disease susceptibility. For more information, email admin.modgene@gmail.com. END
Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques
Results could lead to new strategies for prevention and therapy
2011-03-04
ELSE PRESS RELEASES FROM THIS DATE:
Pat Vitucci Launches Second Radio Show in San Francisco Bay Area
2011-03-04
Pat Vitucci, a Bay Area Independent Financial Advisor, recently launched his second weekly radio program called "Sound Money- A Conservative Approach To Investing". The program airs several times each week on Fox News Radio 910 AM and KDIA 1640AM. The 30 minute program focuses on conservative approaches to investing and saving money. "There are many people who prefer products that are relatively conservative with not a lot of risk", says Vitucci, "and that is what this show is all about". Pat Vitucci was also recently named NPC's (National Planning Corporation) #1 producing ...
ATS issues report recommending research priorities in treatment of sleep apnea
2011-03-04
The American Thoracic Society has released a new official report recommending research priorities in incorporating ambulatory management of adults with obstructive sleep apnea (OSA) into healthcare systems. The report identifies barriers preventing incorporation of portable monitor testing into clinical management pathways and recommends research and development needed to address those barriers.
The statement appears in the March 1, 2011, issue of the Proceedings of the American Thoracic Society.
It is estimated that OSA occurs in roughly 20 million Americans, and ...
Solving the puzzle of Henry VIII
2011-03-04
DALLAS (SMU) – Blood group incompatibility between Henry VIII and his wives could have driven the Tudor king's reproductive woes, and a genetic condition related to his suspected blood group could also explain Henry's dramatic mid-life transformation into a physically and mentally-impaired tyrant who executed two of his wives.
Research conducted by bioarchaeologist Catrina Banks Whitley while she was a graduate student at SMU (Southern Methodist University) and anthropologist Kyra Kramer shows that the numerous miscarriages suffered by Henry's wives could be explained ...
Denver Wedding Photographer Reveals Photo Tips and Top 10 Colorado Destinations for Spring Wedding Photos
2011-03-04
Spring is a wonderful time of year to get married -- temperatures are warming and trees and flowers are in bloom - the perfect time for new beginnings. According to Denver wedding photographer Matt Kelly of Ambisuite Weddings, "Each season has its own unique beauty, and photographing a wedding in any given season has its special challenges. Spring, however, is a breathtaking time for taking wedding photographs."
Tips for beautiful springtime wedding pictures
Whether you are holding your spring wedding indoors or outdoors, the wedding photographer should know how to ...
Oldest objects in solar system indicate a turbulent beginning
2011-03-04
LIVERMORE, Calif. – Scientists have found that calcium, aluminum-rich inclusions (CAIs), some of the oldest objects in the solar system, formed far away from our sun and then later fell back into the mid-plane of the solar system.
The findings may lead to a greater understanding of how our solar system and possibly other solar systems formed and evolved.
CAIs, roughly millimeter- to centimeter in size, are believed to have formed very early in the evolution of the solar system and had contact with nebular gas, either as solid condensates or as molten droplets. Relative ...
Soot packs a punch on Tibetan Plateau's climate
2011-03-04
RICHLAND, Wash. – In some cases, soot – the fine, black carbon silt that is released from stoves, cars and manufacturing plants – can pack more of a climatic punch than greenhouse gases, according to a paper published in the journal Atmospheric Chemistry and Physics.
Researchers at the Department of Energy's Pacific Northwest National Laboratory, the University of Michigan and NOAA found that soot landing on snow on the massive Tibetan Plateau can do more to alter snowmelt and monsoon weather patterns in Asia than carbon dioxide and soot in the air. Soot on snow causes ...
"Wealth Masters International" Announces Their March Consultant of the Month, Robert Bob Chappell, Owner of Home Based Company, LLC
2011-03-04
Wealth Masters International March's Consultant of the Month: Bob Chappell of Home Based Company, LLC
On the first of March, the phone rings and I hear "Bob, it's Karl Bessey here. I just wanted to let you know that you have been chosen 'WMI Consultant of the Month.'"
My initial thought was "Wow... me? But there are so many more deserving people!"
Let me say that I am completely humbled and honored to receive this call from Karl.
I am so grateful that I found Wealth Masters International (Kip and Karl's Dream) through the three points of Wealth, Health and Wisdom ...
String blossom thinner proves effective across stages of bloom development
2011-03-04
BIGLERVILLE, PA—Blossom or fruitlet thinning is a labor-intensive part of commercial peach and nectarine production. The use of mechanical string blossom thinners has been shown to reduce labor requirements and improve fruit size in peach crops, but stone fruit producers have needed more information about the range of thinning times. New research from Tara Auxt Baugher and colleagues from The Pennsylvania State University and Penn State Cooperative Extension gives producers sought-after data about optimum thinning times.
Baugher said that, prior to this study on bloom ...
APS-Hoods Announces Turnkey Hood Installation Training in Las Vegas, Nevada
2011-03-04
American Professional Services (APS) recently announced that it is offering a commercial hood installation training program in the Los Vegas, Nevada area. The training will include how to install HVAC (Heating, Ventilating, and Air Conditioning) and fire suppression systems for businesses currently involved in restaurant construction, and for businesses running commercial kitchens needing an upgrade.
With headquarters in Denver, Colorado, APS specializes in commercial hood sales and professional cleaning services for commercial exhaust hood systems throughout the country.
When ...
Former Federal Reserve Chairman Alan Greenspan speaks out on the costs of government activism
2011-03-04
NEW YORK—March 3, 2011 — In an article to be published in the forthcoming issue of International Finance, Dr. Alan Greenspan, former chairman of the Federal Reserve, issues a major analysis of the U.S. government's economic recovery and reform efforts since the collapse of Lehman Brothers in September 2008.
Greenspan calculates that long-term fixed corporate investment "is now at levels, relative to cash flow, that we have not experienced since 1940." This shortfall, he explains, accounts for much of the tepid recovery and current abnormally high levels of unemployment. ...
LAST 30 PRESS RELEASES:
Insulin resistance is linked to over 30 diseases – and to early death in women, study of people in the UK finds
Innovative semaglutide hydrogel could reduce diabetes shots to once a month
Weight loss could reduce the risk of severe infections in people with diabetes, UK research suggests
Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions
Better cardiovascular health in early pregnancy may offset high genetic risk
Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
IASLC Global Survey on biomarker testing reveals progress and persistent barriers in lung cancer biomarker testing
Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors
Just how dangerous is Great Salt Lake dust? New research looks for clues
Maroulas appointed Associate Vice Chancellor, Director of AI Tennessee
New chickadee research finds cognitive skills impact lifespan
Cognitive behavioral therapy enhances brain circuits to relieve depression
Terasaki Institute awarded $2.3 Million grant from NIH for organ transplantation research using organs-on-a-chip technology
Atoms on the edge
Postdoc takes multipronged approach to muon detection
Mathematical proof: Five satellites needed for precise navigation
Scalable, multi-functional device lays groundwork for advanced quantum applications
Falling for financial scams? It may signal early Alzheimer’s disease
Integrating MRI and OCT for new insights into brain microstructure
Designing a normative neuroimaging library to support diagnosis of traumatic brain injury
Department of Energy announces $68 million in funding for artificial intelligence for scientific research
DOE, ORNL announce opportunity to define future of high-performance computing
Molecular simulations, supercomputing lead to energy-saving biomaterials breakthrough
Low-impact yoga and exercise found to help older women manage urinary incontinence
Genetic studies reveal new insights into cognitive impairment in schizophrenia
Researcher develops technology to provide cleaner energy and cleaner water
Expect the unexpected: nanoscale silver unveils intrinsic self-healing abilities
nTIDE September 2024 Jobs Report: Gains in employment for people with disabilities appear to level off after reducing gaps with non-disabled workers
Wiley enhances NMR Spectral Library Collection with extensive new databases
[Press-News.org] Scripps Research study points to liver, not brain, as origin of Alzheimer's plaquesResults could lead to new strategies for prevention and therapy